Table 5 –
Follow-up time for RFS analysis (see figure 4), stratified by FDG-PET/CT SUVmax result
| SUVmax | N | Median follow-up time (IQR, range), months |
|---|---|---|
| Positive (≥ 1.8) | 142 | 23.7 (10.7–25.1, 0–35.6) |
| Negative (< 1.8) | 66 | 24.2 (17.5–25.5, 0–34.6) |
| Total | 208 | 23.9 (12.4–25.2, 0–35.6) |
IQR, interquartile range; RFS, recurrence-free survival.